• Home
  • Insight
  • Blog
  • Business
  • Entertainment
  • Health
  • Politics
  • Shop
    • Gift Shop
    • Value Shop
    • Store
    • Bargain Shop
    • Discount
  • Sports
  • Tech
  • Travel
  • USA
  • Video
  • World
    • Asia
    • Africa
    • South America
    • North America
    • Europe
    • Oceania
Wednesday, November 18, 2026
No Result
View All Result
Subscribe Now
  • Home
  • Insight
  • Blog
  • Business
  • Entertainment
  • Health
  • Politics
  • Shop
    • Gift Shop
    • Value Shop
    • Store
    • Bargain Shop
    • Discount
  • Sports
  • Tech
  • Travel
  • USA
    FAA Administrator Takes Responsibility as Mullin Faces Tough Questions Over Nationwide Ground Stop

    FAA Administrator Takes Responsibility as Mullin Faces Tough Questions Over Nationwide Ground Stop

    Mary Peltola Emerges Victorious in Alaska Senate Race, Making History for Democrats

    Mary Peltola Emerges Victorious in Alaska Senate Race, Making History for Democrats

    Stranded in Conflict: Palestinians Navigate the Tenuous Balance of War and Peace Amid Ceasefire Efforts

    Stranded in Conflict: Palestinians Navigate the Tenuous Balance of War and Peace Amid Ceasefire Efforts

    Trump Administration Revokes Pay Increase for Head Start Educators

    Trump Administration Revokes Pay Increase for Head Start Educators

    Unexpected Triumph: Gay Candidates Achieve Unforeseen Victories in Challenging Races

    Unexpected Triumph: Gay Candidates Achieve Unforeseen Victories in Challenging Races

    Microsoft Outlook Experiences Prolonged Outage Affecting Users Nationwide

    Microsoft Outlook Experiences Prolonged Outage Affecting Users Nationwide

    Gunfire Erupts in D.C.: Authorities Search for Suspect Amid Rising Concerns Over Public Safety

    Gunfire Erupts in D.C.: Authorities Search for Suspect Amid Rising Concerns Over Public Safety

    LAUSD Takes Strong Action Against Hate Speech Following Racial Slur Incidents

    LAUSD Takes Strong Action Against Hate Speech Following Racial Slur Incidents

    Beloved Former Los Angeles Times Columnist Steve Harvey Passes Away at 80

    Beloved Former Los Angeles Times Columnist Steve Harvey Passes Away at 80

  • Video
  • World
    • Asia
    • Africa
    • South America
    • North America
    • Europe
    • Oceania
The Insight Post
  • Home
  • Insight
  • Blog
  • Business
  • Entertainment
  • Health
  • Politics
  • Shop
    • Gift Shop
    • Value Shop
    • Store
    • Bargain Shop
    • Discount
  • Sports
  • Tech
  • Travel
  • USA
    FAA Administrator Takes Responsibility as Mullin Faces Tough Questions Over Nationwide Ground Stop

    FAA Administrator Takes Responsibility as Mullin Faces Tough Questions Over Nationwide Ground Stop

    Mary Peltola Emerges Victorious in Alaska Senate Race, Making History for Democrats

    Mary Peltola Emerges Victorious in Alaska Senate Race, Making History for Democrats

    Stranded in Conflict: Palestinians Navigate the Tenuous Balance of War and Peace Amid Ceasefire Efforts

    Stranded in Conflict: Palestinians Navigate the Tenuous Balance of War and Peace Amid Ceasefire Efforts

    Trump Administration Revokes Pay Increase for Head Start Educators

    Trump Administration Revokes Pay Increase for Head Start Educators

    Unexpected Triumph: Gay Candidates Achieve Unforeseen Victories in Challenging Races

    Unexpected Triumph: Gay Candidates Achieve Unforeseen Victories in Challenging Races

    Microsoft Outlook Experiences Prolonged Outage Affecting Users Nationwide

    Microsoft Outlook Experiences Prolonged Outage Affecting Users Nationwide

    Gunfire Erupts in D.C.: Authorities Search for Suspect Amid Rising Concerns Over Public Safety

    Gunfire Erupts in D.C.: Authorities Search for Suspect Amid Rising Concerns Over Public Safety

    LAUSD Takes Strong Action Against Hate Speech Following Racial Slur Incidents

    LAUSD Takes Strong Action Against Hate Speech Following Racial Slur Incidents

    Beloved Former Los Angeles Times Columnist Steve Harvey Passes Away at 80

    Beloved Former Los Angeles Times Columnist Steve Harvey Passes Away at 80

  • Video
  • World
    • Asia
    • Africa
    • South America
    • North America
    • Europe
    • Oceania
No Result
View All Result
No Result
View All Result
Home Science

CRISPR could be used to treat UTIs, early trial hints

by Theinsightpost
August 16, 2024
in Science
0 0
0
CRISPR could be used to treat UTIs, early trial hints

Viruses armed with the gene-editing tool CRISPR could someday be used to treat urinary tract infections (UTIs), results from an early clinical trial suggest.

However, the experimental treatment, which would be used in tandem with traditional antibiotics, still has more tests to undergo before it could be approved for clinical use.

The treatment harnesses bacteriophages, or viruses that infect bacteria. Also called “phages” for short, the viruses are being developed as a potential alternative to conventional antibiotic drugs.

One reason phages are appealing is they can be incredibly selective, taking aim at only specific bacterial strains. This sidesteps problems posed by broader-spectrum antibiotics, which can kill a range of bacteria and thus pressure many microbes to evolve antibiotic resistance. Broad-spectrum antibiotics can also inflict collateral damage on helpful bacteria, including those in the gut microbiome.

Related: Dangerous ‘superbugs’ are a growing threat, and antibiotics can’t stop their rise. What can?

Phages aren’t totally immune to resistance; bacteria can evolve strategies to survive the attack of individual viruses. However, multiple phages can be combined into one treatment, forcing the bacteria into a corner.

That’s the case for LBP-EC01, the new phage therapy being tested for UTIs. Specifically, LBP-EC01 is designed to kill Escherichia coli, the main culprit behind UTIs.

Get the world’s most fascinating discoveries delivered straight to your inbox.

Made by the company Locus Biosciences, the experimental treatment was described in a paper published Aug. 9 in the journal The Lancet Infectious Diseases. LBP-EC01 would be used alongside a traditional antibiotic to boost that antibiotic’s effectiveness and thus reduce the dose needed to cure an infection. (Some other phage therapies are being considered as standalone treatments.)

LBP-EC01 contains six phages, three of which are “lytic,” meaning they invade bacterial cells and split them open. The three remaining phages are engineered to carry genes for a CRISPR system. CRISPR is a precise tool that can be used to cut through specific sequences within DNA. Once it’s inside an E. coli cell, this CRISPR machinery goes after bits of the bacterial genome that are crucial to the microbe’s survival.

“The real draw of it is that it is a sequence-specific tool,” meaning the treatment targets only the DNA you tell it to and not sequences present in other cells, Chase Beisel, co-founder and scientific adviser of Locus Biosciences, told Live Science in 2023. So, once administered to a patient, “the CRISPR machinery gets into a set of cells, but only those that have the sequence or sequences you picked will be attacked and killed,” he explained.

Locus Biosciences has just completed the first part of a two-part trial of LBP-EC01. The treatment is being tested for uncomplicated UTIs, meaning those that don’t involve structural abnormalities in the urinary tract or additional medical problems, such as having a weakened immune system.

The first part of the trial, which included 39 adult female patients, was aimed at identifying a safe dose of the treatment to move into further testing. All of the patients had a history of at least one drug-resistant UTI caused by E. coli in the year prior to the trial.

Tests conducted in the trial ultimately zeroed in on a quick, three-day course of the treatment that’s given alongside an antibiotic called trimethoprim-sulfamethoxazole (common brand name Bactrim). No serious side effects were observed with this dosing regimen. In addition, samples of the patients’ UTI bacteria didn’t show signs of evolving resistance after the treatment.

Related: New UTI vaccine wards off infection for years, early studies suggest

In a subset of 16 patients, the scientists looked more closely at how well the treatment worked against the UTIs. They saw a “rapid reduction of E. coli” in patients’ urine within four hours of the first dose. All 16 patients’ UTI symptoms had completely resolved by the 10th day after starting treatment. By then, 14 of the 16 had low enough E. coli levels in their urine to be considered cured of the infection, as well.

Eleven of these 16 patients were infected by bacteria that were resistant to TMP-SMX at baseline, the study authors noted. That suggests that the phage treatment worked synergistically with the antibiotic, lowering the bacteria’s defenses so even antibiotic-resistant infections could be cleared.

However, because the main goal of this study was to select a dose, not to test the treatment’s efficacy, the second phase of the trial will now compare LBP-EC01 to a placebo. In addition, the first leg of the trial was quite small, the study authors noted, but the next phase will include up to 288 participants.

There’s more work to be done to move LBP-EC01 toward an official approval. However, broadly speaking, “I can see these [types of treatments] coming about in the five- to 10-year time frame,” Beisel previously told Live Science.

Ever wonder why some people build muscle more easily than others or why freckles come out in the sun? Send us your questions about how the human body works to community@livescience.com with the subject line “Health Desk Q,” and you may see your question answered on the website!

ShareTweetSend
Previous Post

China’s new loans hit a 15-year low, but investors ‘should not panic’

Next Post

AP Week in Pictures: Latin America and Caribbean

Related News

Groundbreaking Electric Comb Promises Hair Regrowth in Mice Within Four Weeks, Paving the Way for Future Hair-Loss Solutions
Science

Groundbreaking Electric Comb Promises Hair Regrowth in Mice Within Four Weeks, Paving the Way for Future Hair-Loss Solutions

November 18, 2026
Miniature LSD Doses Administered in Rapid Succession Show Antidepressant Potential in Mice: Exploring the Impact of Timing vs. Tolerance
Science

Miniature LSD Doses Administered in Rapid Succession Show Antidepressant Potential in Mice: Exploring the Impact of Timing vs. Tolerance

November 14, 2026
Investigation Underway: Experts Seek Answers Behind Sudden Brooklyn Building Collapse
Science

Investigation Underway: Experts Seek Answers Behind Sudden Brooklyn Building Collapse

November 12, 2026
Preserve the Unseen: The Essential Role of Parasites in Ecosystems
Science

Preserve the Unseen: The Essential Role of Parasites in Ecosystems

November 11, 2026
Next Post
AP Week in Pictures: Latin America and Caribbean

AP Week in Pictures: Latin America and Caribbean

Discussion about this post

Subscribe To Our Newsletters

    Customer Support


    1251 Wilcrest Drive
    Houston, Texas
    77042 USA
    Call-832.795.1420
    e-mail – news@theinsightpost.com

    Subscribe To Our Newsletters

      Categories

      • Africa
      • Africa-East
      • African Sports
      • American Sports
      • Arts
      • Asia
      • Australia
      • Business
      • Business Asia
      • Business- Africa
      • Canada
      • Defense
      • Education
      • Egypt
      • Energy
      • Entertainment
      • Europe
      • European Soccer
      • Finance
      • Germany
      • Ghana
      • Health
      • Insight
      • International
      • Investing
      • Japan
      • Latest Headlines
      • Life & Living
      • Markets
      • Mobile
      • Movies
      • New Zealand
      • Nigeria
      • Politics
      • Scholarships
      • Science
      • South Africa
      • South America
      • Sports
      • Tech
      • Travel
      • Travel-Africa
      • UK
      • USA
      • Weather
      • World
      No Result
      View All Result

      Recent News

      Expert Challenges Obama-Era Housing First Initiative Following LAHSA Budget Reductions

      Expert Challenges Obama-Era Housing First Initiative Following LAHSA Budget Reductions

      November 18, 2026
      Alphabet’s Valuation Estimated at 1 Through Discounted Cash Flow Analysis

      Alphabet’s Valuation Estimated at $291 Through Discounted Cash Flow Analysis

      November 18, 2026
      Crimea Bridge Targeted in Renewed Assault, Reports Russian Governor

      Crimea Bridge Targeted in Renewed Assault, Reports Russian Governor

      November 18, 2026
      FAA Administrator Takes Responsibility as Mullin Faces Tough Questions Over Nationwide Ground Stop

      FAA Administrator Takes Responsibility as Mullin Faces Tough Questions Over Nationwide Ground Stop

      November 18, 2026
      • Home
      • Advertise With Us
      • About Us
      • Corporate
      • Consumer Rewards
      • Forum
      • Privacy Policy
      • Social Trends

      Theinsightpost ©2026 | All Rights Reserved. Theinsightpost is an Elnegy LLC company, registered in Texas, USA

      Welcome Back!

      Login to your account below

      Forgotten Password?

      Retrieve your password

      Please enter your username or email address to reset your password.

      Log In

      Add New Playlist

      We are using cookies to give you the best experience on our website.

      You can find out more about which cookies we are using or switch them off in .

      No Result
      View All Result
      • Home
      • Insight
      • Blog
      • Business
      • Entertainment
      • Health
      • Politics
      • Shop
        • Gift Shop
        • Value Shop
        • Store
        • Bargain Shop
        • Discount
      • Sports
      • Tech
      • Travel
      • USA
      • Video
      • World
        • Asia
        • Africa
        • South America
        • North America
        • Europe
        • Oceania

      Theinsightpost ©2026 | All Rights Reserved. Theinsightpost is an Elnegy LLC company, registered in Texas, USA

      The Insight Post
      Powered by  GDPR Cookie Compliance
      Privacy Overview

      This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

      Strictly Necessary Cookies

      Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

      Cookie Policy

      More information about our Cookie Policy